ELN Reports in-line
Elan reports in-line (ELN) 7.99 :According to Reuters Estimates ELN reported Q2 (Jun) loss of $0.27 per share, ex items, in-line with the Reuters Estimates consensus of ($0.27); revenues rose 9.4% year/year to $118.6 mln vs the $123.1 mln consensus. Co stated: "While we await the outcome of the ongoing Tysabri safety evaluation, we continue to prudently invest in Tysabri and remain capable and committed to re-introducing it as a therapeutic option for patients should it be appropriate." The company has a CC scheduled for 8:30am.
ELN CC
ELN CC
0 Comments:
Post a Comment
<< Home